Clarithromycin Inhibits Progeny Virus Production from Human Influenza Virus-Infected Host Cells
- 1 January 2008
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 31 (2) , 217-222
Abstract
In vitro effects of macrolide clarithromycin (CAM) on influenza A virus-infected cells were examined using plaque reduction assay by treating cells either before or after viral adsorption. The significant inhibitory effect on influenza virus infection was detected only when the cells were treated with CAM after viral adsorption. The predominant inhibitory effect was observed during 4—7th hour after viral adsorption using viral production assay. CAM did not exhibit inhibitory effects on influenza virus hemagglutination, membrane fusion and viral sialidase activities. These findings indicate that CAM acts on a middle to late stage of the viral replication cycle resulting in inhibition of progeny virus production from the infected cells.Keywords
This publication has 35 references indexed in Scilit:
- Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic AgentsCurrent Pharmaceutical Design, 2007
- Antiviral agents active against influenza A virusesNature Reviews Drug Discovery, 2006
- Clarithromycin is an effective immunomodulator in experimental pyelonephritis caused by pan-resistant Klebsiella pneumoniaeJournal of Antimicrobial Chemotherapy, 2006
- InfluenzaThe Lancet, 2003
- The Japanese Experience with Vaccinating Schoolchildren against InfluenzaNew England Journal of Medicine, 2001
- Thujaplicin–copper chelates inhibit replication of human influenza virusesAntiviral Research, 1998
- Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B1994
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Membrane FusionScience, 1992
- Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice.Journal of Clinical Investigation, 1990